Stenting atherosclerotic renal arteries: time to be less aggressive

James F Simon1

  • 1Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA. simonj2@ccf.org

Insights

Percutaneous intervention for renal artery stenosis shows high technical success but limited blood pressure benefits. Better methods are needed to predict patient benefit and prevent complications like atheroembolism.

Area of Science:

  • Cardiovascular medicine
  • Interventional nephrology
  • Medical device technology

Background:

  • Percutaneous intervention (PI) is increasingly used for atherosclerotic renal artery stenosis (ARAS).
  • Stent use has improved technical success rates for PI in ARAS.
  • Incidental discovery of ARAS during other angiographic procedures is common.

Purpose of the Study:

  • To evaluate the efficacy of PI for atherosclerotic renal artery stenosis.
  • To identify predictors of patient benefit from PI.
  • To explore methods for preventing adverse events, including atheroembolism.

Main Methods:

  • Review of randomized trials comparing PI to medical management for ARAS.
  • Analysis of factors influencing blood pressure control and renal function outcomes.
  • Assessment of complication rates, focusing on atheroembolism.

Main Results:

  • Randomized trials show PI offers minimal benefit in controlling blood pressure in ARAS patients.
  • The procedure may pose risks to renal function, potentially harming as many patients as it helps.
  • Current methods lack sufficient predictive power for identifying patients who will benefit from PI.

Conclusions:

  • Despite technical success, PI for ARAS has questionable clinical utility regarding blood pressure control.
  • Risk of renal function deterioration necessitates careful patient selection and risk stratification.
  • Further research is crucial for developing predictive models and preventative strategies for PI-related complications.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...